SightfileU.S. market data from official filings

VIATRIS INC (VTRS)

Name: VIATRIS INC (VTRS) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001792044 · EDGAR filings · Updated 2026-07-01

VIATRIS INC (VTRS) has reported institutional ownership of 85.0%, with 1,012 institutional managers holding positions valued at $13.4B per the latest 13F reporting period.

Institutional ownership

85.0%

Institutional managers

1,012

Reported 13F value

$13.4B

Insider activity

98 trans.

$405.8K net buying

Latest updates

2026-07-01 — Insider transaction reported (Form 4)
2026-07-01 — Insider transaction reported (Form 4)
2026-07-01 — Current report (8-K) filed
2026-06-26 — Insider transaction reported (Form 4)
2026-06-25 — Notice of proposed sale filed (Form 144)
2026-06-18 — Current report (8-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, VIATRIS INC has 1,012 institutional holders and institutional ownership of 85.0%.

Insider activity

Insiders reported 98 transactions (4 buys, 2 sells) across 18 reporting insiders, with a net reported value of $405.8K.

Related companies

COOPER COS INC (COO) · INSULET CORP (PODD) · BRIDGEBIO PHARMA INC (BBIO) · NEUROCRINE BIOSCIENCES INC (NBIX) · ELANCO ANIMAL HEALTH INC (ELAN) · IONIS PHARMACEUTICALS INC (IONS)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-01.